Strategy | Finance Blog
Healthcare Private Placement and M&A Transactions Review Week Ending June 19, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Elucida Oncology: The company raised $45.2 million of venture funding from undisclosed investors on June 15, 2023. Elucida Oncology is a developer of therapeutics designed to target cancer with...
Consumer Private Placement and M&A Transactions Review Week Ending June 19, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Tomorrow.io: The company raised $87 million in Series E venture funding in a deal led by Activate Capital Partners on June 14, 2023, putting the company's pre-money valuation at $350 million....
Technology Private Placement and M&A Transactions Review Week Ending June 11, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Cohere: The company raised $270 million of Series C venture funding in a deal led by Inovia Capital on June 8, 2023, putting the company's pre-money valuation at $1.75 billion. Nvidia,...
Healthcare Private Placement and M&A Transactions Review Week Ending June 11, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions ITM Isotopen Technologien München: The company received EUR 256 million of development capital from Temasek Holdings, Carbyne Equity Partners, Nextech Invest, Athos (Family Office), BlackRock...
Consumer Private Placement and M&A Transactions Review Week Ending June 11, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Uncommon: The company raised GBP 24.5 million through a combination of debt and Series A venture funding in a deal led by Lowercarbon Capital and Balderton Capital on June 9, 2023, putting the...
Technology Private Placement and M&A Transactions Review Week Ending June 4, 2023
Strategy | Financing Highlight Private Placement / Financing TransactionsLightmatter: The company raised $153.3 million of Series C venture funding in a deal led by SIP Global Partners on May 31, 2023, putting the company's pre-money valuation at $480 million. GV,...
Healthcare Private Placement and M&A Transactions Review Week Ending June 4, 2023
Strategy | Financing Highlight Private Placement / Financing TransactionsEikon Therapeutics: The company raised $140.8 million of Series C venture funding from undisclosed investors on June 1, 2023. The company is a developer of a drug discovery platform designed to...
Consumer Private Placement and M&A Transactions Review Week Ending June 4, 2023
Strategy | Financing Highlight Private Placement / Financing TransactionsCascadia Seaweed: The company is in the process of raising CAD 10 million of an undisclosed targeted amount of Series A venture funding in the combination of convertible debt from Bloomsbury...
Technology Private Placement and M&A Transactions Review Week Ending May 28, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Builder: The company raised $250 million of Series D venture funding in a deal led by Qatar Investment Authority on May 23, 2023. Microsoft, Epiq Capital, Insight Partners, Ion Pacific, Jungle...
Healthcare Private Placement and M&A Transactions Review Week Ending May 28, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions ReNAgade Therapeutics: The company raised $300 million of Series A venture funding in a deal led by MPM Capital and F2 Ventures on May 23, 2023. BioImpact Capital and Alexandria Venture...